Language
- 简体中文
- English

Home page

Radiotherapy Protective Hydrogels

Key words:

Products News

Products

News

Reunion Ruixun | Reunion Biotechnology Receives “US FDA Breakthrough Device” Designation, Entering the Global Frontline of Medical Hydrogel Innovation

Reunion Ruixun | Reunion Biotechnology’s Respacio® Tumor Radiotherapy “Absorbable Isolation Hydrogel” Has Received Approval from the National Medical Products Administration (NMPA) for Market Launch

Reunion Ruixun | Reunion Biotechnology Completes Nearly 100 Million Yuan in Series C Funding

Reunion Rui Xun | Reunion Bio Honored on the “2025 Innovation Technology Achievement List,” Empowering Shanghai’s Biopharmaceutical Industry with Original Technologies

Reunion Ruixun | Reunion Bio’s Tumor “Embolization Hydrogel” Enters the National Innovative Medical Device “Green Channel”

The group standard “Guidelines for Quality Management of Contract Manufacturing of Medical Devices in the Yangtze River Delta Region,” with Reunion Bio as the primary drafting unit, has been officially released.

Contact Us
Telephone: 021-51592768
E-mail: cs@reunionmed.com
Address: Floor 2, Building 7, 1630 Yecheng Road, Jiading District, Shanghai

Scan QR Code

Copyright©2024 Shanghai Reunion Biotechnology Co., Ltd.

Powered by www.300.cn SEO

Business License